The insulin doses administered to humans intranasally in order to improve their cognitive functions are usually 20 or 40 IU, 40 IU was shown to have more pronounced positive effect on people with MCI or Alzheimer’s disease, see, for example, [6,28]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.